Related Experiment Video
Updated: Apr 21, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Meta-analysis for curative effect of lobectomy and segmentectomy on non-small cell lung cancer
Qiang Tan1, Jia Huang1, Zhengping Ding1
1Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200030, China.
Objective:
To systematically evaluate 5-year survival, local recurrence rate, long-term recurrence rate and complications for lobectomy and segmentectomy in the treatment of NSCLC.
Methods:
Articles on randomized and non-randomized clinical studies of 5-year survival, local recurrence, long-term recurrence and complications after lobectomy and segmentectomy for treatment of NSCLC.
Results:
Among the included patients, no difference was found between the two groups in local recurrence. However, the incidence of complication in the segmentectomy group was found to be significantly higher than in the lobectomy group.
Conclusion:
For treatment of NSCLC, as compared with segmentectomy, suggesting that lobectomy is the preferable method.
